Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.45B 1.26B 1.17B 1.08B 2.03B 139B 2.07B 13.93B 5.46B 67.99B 5.43B 5.31B 234B P/E 2026 *
28.6x
P/E 2027 * 15.5x
Enterprise Value 2.78B 2.43B 2.25B 2.08B 3.91B 267B 3.98B 26.82B 10.52B 131B 10.46B 10.23B 451B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.52x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week+4.81%
Current month+1.89%
1 month+4.81%
3 months+65.46%
6 months+46.05%
Current year+47.34%
1 week 17.01
Extreme 17.01
18.91
1 month 17.01
Extreme 17.01
18.92
Current year 8.7
Extreme 8.7
18.92
1 year 8.7
Extreme 8.7
18.92
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Tax

Controller/Auditor

-937 0.0012%
01/07Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%+4.81%+49.88%-57.40% 1.45B
-2.65%-6.36%-32.03%-16.85% 160B
-5.00%-5.04%-11.28%-9.18% 107B
-1.37%-0.81%+1.67%+57.78% 59.56B
+0.35%-0.02%+43.33%+56.20% 52.51B
-1.50%-3.15%-14.52%-41.64% 42.39B
-3.68%-8.93% - - 34.31B
-3.24%+0.46%-13.39%-46.18% 29.46B
-0.20%+0.69%+59.71%-6.90% 25.41B
-3.83%-2.76%-7.24%-8.58% 21.15B
Average -2.18%-0.09%+8.46%-8.08% 53.37B
Weighted average by Cap. -2.56%-0.93%-7.10%-1.72%

Financials

2026 *2027 *
Net sales 1.68B 1.46B 1.35B 1.25B 2.36B 161B 2.4B 16.15B 6.34B 78.83B 6.3B 6.16B 271B 1.73B 1.51B 1.4B 1.29B 2.43B 166B 2.48B 16.67B 6.54B 81.37B 6.5B 6.36B 280B
Net income 42.73M 37.34M 34.52M 31.89M 60.06M 4.1B 61.15M 412M 162M 2.01B 161M 157M 6.92B 74.56M 65.16M 60.24M 55.65M 105M 7.16B 107M 718M 282M 3.51B 280M 274M 12.08B
Net Debt 1.34B 1.17B 1.08B 999M 1.88B 129B 1.92B 12.89B 5.06B 62.95B 5.03B 4.92B 217B 1.18B 1.03B 950M 878M 1.65B 113B 1.68B 11.33B 4.44B 55.31B 4.42B 4.32B 190B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
15/07/26 USD 18.30 -1.51% 538,110
13/07/26 USD 18.58 -1.12% 803,323
10/07/26 USD 18.79 +2.18% 951,869
09/07/26 USD 18.39 +6.30% 939,773
08/07/26 USD 17.30 -0.92% 702,386
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.58USD
Average target price
18.00USD
Spread / Average Target
-3.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock